Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients - Wikidata - wikimedia - TriplyDB

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

http://www.wikidata.org/entity/Q34031441

about

Bisphosphonate Related Osteonecrosis of the Jaw: An Update Current state of orthodontic patients under bisphosphonate therapy Dental implants in patients treated with antiresorptive medication - a systematic literature review Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.Effect of bisphosphonates on orthodontic tooth movement-an update The Prevention of Medication-related Osteonecrosis of the Jaw.Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla.Pathophysiology of Osteonecrosis of the Jaws.Atraumatic tooth extraction in patients taking bisphosphonates: a review of literature and experience with three cases.Nitrogen containing bisphosphonates associated osteonecrosis of the jaws: A review for past 10 year literature.Hyperbaric oxygen therapy and osteonecrosis.Nitrogen-containing bisphosphonates modulate the antigenic profile and inhibit the maturation and biomineralization potential of osteoblast-like cells.Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.Radiologic bone loss in patients with bisphosphonate-associated osteonecrosis of the jaws: a case-control study.Analysis of reasons for osteonecrosis of the jaws.Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw.Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).Diabetes Mellitus and Its Association to the Occurrence of Medication-Related Osteonecrosis of the Jaw.Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview.Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.Bone-targeted agents in multiple myeloma.

P2860

Q26801664-4E9EEA01-18F1-4BBF-B7D4-9A060F580834 Q27687136-D74DCCA6-5ECD-457B-B48C-E05C9E239C7F Q28080315-BEABF949-8A1C-43F9-9F97-816268D42E72 Q33771321-FEF6760E-BB06-446D-A291-0BD52CC184ED Q34440107-90289602-23DE-4B9A-B098-5E466A5B39B0 Q35622970-2661B7F4-8170-4174-9348-B4306907AB47 Q36292333-F000FE85-0466-4444-B5E2-93F47A967C9F Q36433392-8A9CE872-65CB-47C7-955E-D219FD9B4309 Q37006852-C83FE261-5E58-47DD-BA04-13CC8F5753DF Q38211712-5B3224C3-A410-4898-A752-4498C564F28F Q38220494-D9B53CEA-57F3-47CD-867F-308A3B53C5A4 Q38803408-E01514AC-53AA-4889-9186-BD99C58ECB9A Q38962310-C8CAF002-3559-4B95-8BDB-4A57DED7BBCD Q44042571-4173D696-E883-494C-9C82-BA74580AD4B3 Q45140811-017CD34F-97B2-4C84-A08D-BBC017C03301 Q46713930-1D5F9457-2D77-4794-BD42-8E1D81269E6F Q54500167-67AB5031-8FA0-4C01-89C2-735B0CFE8AE1 Q54958018-41ABE984-B70A-4F32-90FA-933DBB6174AD Q55075852-96E5449F-24AB-4A88-AEE1-92634F4CF9A6 Q55265048-35273175-74A8-478A-AB0F-B23C1B917B2E Q55384058-A6058395-5F6C-4C62-9B20-63C65458FFAA Q55395268-9ACA404C-D43F-4EBD-ACD5-B4E999E582D8

P2860

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

http://www.wikidata.org/entity/Q34031441

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@ast

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@en

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@nl

type

label

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@ast

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@en

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@nl

prefLabel

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@ast

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@en

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@nl

P1433

Q34031441-F80A5B71-4367-4420-9C30-EDC46CF408FC

P1476

Q34031441-D24822D2-9E99-4547-ADAA-FEE9AB12C504

P2093

Q34031441-19651175-B4B4-4C86-83D5-4A7999630A7A

Q34031441-48DFEB6F-FDA8-4A1E-A33A-CE659A877411

Q34031441-5B0D33DD-EED0-4C5A-AAF6-EC2A6FABBCAC

Q34031441-5BD84821-1B30-4EB1-AA3A-1F00C8B03504

Q34031441-977A601C-53B4-44D8-9C1D-8B917B349654

Q34031441-B10B6E51-E5EF-47BB-AAA8-CA3A5D9D7ED5

Q34031441-EDDFAA82-5D13-4C20-8A74-850BBC55B3E6

P2860

Q34031441-01B64A11-4A4B-440D-BC5F-B26DEAE8EBB6

Q34031441-02EF5145-14A9-463D-A7AB-5B2D63D86EF3

Q34031441-0694AC2B-EFF6-41E2-A645-5BB0C5DB1FD4

Q34031441-0D71FD43-9747-4C06-AF92-043F7A6A998E

Q34031441-15241948-1408-4B48-A407-019890AD5327

Q34031441-188B1969-648C-462B-9F3B-AAF5A9B24621

Q34031441-2140EDD5-B2DB-4365-87A6-4EA2AB66EDE9

Q34031441-30530907-1C33-4D52-9363-0ABB80882251

Q34031441-3A7FD815-3CD1-4BA9-97C9-3161707E0C06

Q34031441-50ED948D-239E-4C9A-8726-93038AFFA6B1

P2888

Q34031441-BA2C9881-91EE-49F5-9F9D-732B3388A4B4

P304

Q34031441-B3F1D32B-A297-4BDC-A35E-467A8418CFF0

P31

Q34031441-3FF517D6-A106-4D2B-BD46-88FB899B53D5

P356

Q34031441-157A2438-E78B-4D72-84BF-50146AA4E246

P478

Q34031441-0F0629BE-B1BC-40A1-AE69-FF3C35B89962

P50

Q34031441-2E35A87A-0731-4271-AFB7-A163CD7F25EA

Q34031441-8B3D3442-3DEA-4FF5-ACE1-AF042E2639FF

P577

Q34031441-F5D4ACA0-93A2-45C3-A871-F8437172032D

P6179

Q34031441-904AE05C-31F6-4ACF-AD5E-971902738CBF

P698

Q34031441-C78CA919-C2F5-4970-8D6A-F93BAF1095F2

P932

Q34031441-3E04C6F0-E7B4-4911-A031-807D589FCECD

P356

P1433

Head & face medicine

P1476

Prevalence of bisphosphonate a ...... s in multiple myeloma patients

@en

P2093

Christina Blum

http://www.w3.org/2001/XMLSchema#string

Heinold Gamm

http://www.w3.org/2001/XMLSchema#string

Joachim Beck

http://www.w3.org/2001/XMLSchema#string

Knut A Grötz

http://www.w3.org/2001/XMLSchema#string

Laura Reinsch

http://www.w3.org/2001/XMLSchema#string

Norbert Frickhofen

http://www.w3.org/2001/XMLSchema#string

Wilfried Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Cellular and molecular mechanisms of action of bisphosphonates.

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review.

Multiple myeloma/hypercalcemia.

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-160X-6-11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Christian Walter

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032684424

http://www.w3.org/2001/XMLSchema#string

P698

20615236

http://www.w3.org/2001/XMLSchema#string

P932

2912876

http://www.w3.org/2001/XMLSchema#string